CYTK - Cytokinetics, Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue13,368106,40728,658
Cost of Revenue---
Gross Profit13,368106,40728,658
Operating Expenses
Research Development90,29659,89746,398
Selling General and Administrative36,46827,82319,667
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-113,39618,687-37,407
Income from Continuing Operations
Total Other Income/Expenses Net2,602464174
Earnings Before Interest and Taxes-110,79419,151-37,233
Interest Expense16,9962,698268
Income Before Tax-127,79016,453-37,501
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-127,79016,453-37,501
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-127,79016,453-37,501
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-127,79016,453-37,501